US Patent 7959910 C-terminally truncated interferon alpha variants
Patent 7959910 was granted and assigned to Biolex Therapeutics on June, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7959910 C-terminally truncated interferon alpha variants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.